Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG

Prenatal Diagnosis

Volumn 19, Issue 4, 1999, Pages 351-359

  Cole, Laurence A ^a   Shahabi, Shohreh ^a   Oz, Utku A ^a   Rinne, Kirsi M ^a   Omrani, Aziza ^a   Bahado Singh, Ray O ^a   Mahoney, Maurice J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Down syndrome; Glycosylation; hCG; Human chorionic gonadotrophin; Hyperglycosylated hCG; Oligosaccharide; Prenatal diagnosis; Screening

Indexed keywords

CHORIONIC GONADOTROPIN; CREATININE; ESTRIOL;

ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DOWN SYNDROME; FEMALE; FETUS; GENETIC ANALYSIS; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MATERNAL AGE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SCREENING TEST; URINALYSIS;

EID: 0032936975     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199904)19:4<351::AID-PD546>3.0.CO;2-X     Document Type: Article

References (23)

1. Ashitaja Y, Nishimura R, Takemori M, Tojo S. 1980. Production and secretion of hCG and hCG subunits by trophoblastic tissue. In: Segal SJ (ed.). Chorionic Gonadotropin. New York: Plenum Press; 147-176.
2. Auxter S. 1997. What's next in the hCG patent controversy? Clin Labor News 23: 1-3.
3. Bogart MH, Pandian MR, Jones OW. 1987. Abnormal maternal serum hCG levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 7: 623-630.
4. Canick JA. 1990. Screening for Down syndrome using maternal serum alpha-fetoprotein, unconjugated estriol and hCG. J Clin Immunoassay 13: 30-33.
5. Cole LA, Kardana A, Andrade-Gordon P, Gawinowicz MA, Morris JC, Bergert ER, O'Connor J, Birken S. 1991. The Heterogeneity of hCG: III. The occurrence, biological and immunological activities of nicked hCG. Endocrinology 129: 1559-1567.
6. Cole LA, Kardana A, Park S-Y, Braunstein GD. 1993. The deactivation of hCG by nicking and dissociation. J Clin Endocrinol Metab 76: 704-710
7. Cole LA, Cermik D, Bahado-Singh RO. 1997a. Oligosaccharide variants of hCG-related molecules: potential screening markers for Down syndrome. Prenat Diagn 17: 1188-1190.
8. Cole LA, Jacobs M, Isozaki T, Palomaki GE, Bahado-Singh RO, Mahoney MJ. 1997b. Screening for Down syndrome using urine hCG free β-subunit in the second trimester of pregnancy. Prenat Diagn 17: 1107-1111.
9. Cole LA, Omrani A, Cermik D, Bahado Singh RO, Mahoney MJ. 1998. Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening. Prenat Diagn 18: 926-933.
10. Cole LA, Rinne KM, Mahajan SM, Oz UA, Shahabi S, Mahoney MJ, Bahado-Singh RO. 1999. New screening tests for Down syndrome: I. Fresh urine β-core fragment. Prenat Diagn 19: 340-350.
11. Elliott M, Kardana A, Lustbader JW, Cole LA. 1997. Carbohydrate and peptide structure of the α-and β-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 7: 15-32.
12. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Sailer DN, Bowers GB. 1992. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 327: 588-593.
13. Kingston JE. 1998. Hyperglycosylated human chorionic gonadotropin in preeclampsia, Thesis, Yale University School of Medicine, Yale University, New Haven; 1-27.
14. Merkatz IR, Nitowsky HM, Macri N. 1984. An association between low maternal serum α-fetoprotein and fetal chromosome abnormalities. Am J Obstet Gynecol 148: 886-894.
15. O'Connor JF, Ellish N, Kakuma T, Schlatterer J, Kobalebskaya G. 1998. Differential urinary gonadotropin profiles in early pregnancy and early pregnancy loss. Prenat Diagn 18: 1232-1240.
16. Palomaki GE, Knight GJ, McCarthy J, Haddow JE, Eckfeldt JH. 1993. Maternal serum screening for fetal Down syndrome in the United States: a 1992 survey. Am J Obstet Gynecol 169: 1558-1562.
17. Palomaki GE, Neveux LM, Haddow JE. 1995. Are DADs (discriminant aneuploidy detection) as good as MoMs (multiples of the median)? Am J Obstet Gynecol 173: 1895-1897.
18. Royston P, Thompson SG. 1992. Model based screening by risk with application to Down's syndrome screening. Stat Med 11: 257-268.
19. Shahabi S, Rinne K., Oz U, Bahado-Singh R. Mahoney M, Baumgarten A, Cole LA. 1999. Serum hyperglycosylated hCG, a potential screening test for fetal Down syndrome. Prenat Diagn, in press.
20. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, Knight GJ, Palomaki GE. 1988a. Maternal serum unconjugated oestriol as an antenatal screening test for Down syndrome. Br J Obstet Gynecol 95: 334-341
21. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Cannick JA. 1988b. Maternal serum screening for Down syndrome in early pregnancy. Br Med J 287: 883-887.
22. Wald NJ, Densem J, George L, Muttukrishna S, Knight P. 1996. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 16: 143-153.
23. Zoler ML. 1997. Royalty fees may put hCG test out of business. Ob Gyn News 32: 28-29.